a perfect match

IGS GeboJagema

Strongly growing with IGS’s multi-cavity injection moulds for the medical market.

IGS GeboJagema is specialised in the development, production and validation of high-precision multi-cavity injection moulds for plastic products. The company is focused on the premium segment of the market, where it manufactures its products for injection moulders and leading OEM’s. The moulds produce products for the optical and medical markets, and end-products include contact lenses, insulin pens and inhalers. The company is located in Eindhoven, where it has state-of-the art production facilities.

Nordian and IGS’s management target strong growth in especially the medical business by adding new products and clients, potentially accelerated by an M&A strategy.

type of case:
Commercial excellence

start investment:


“IGS made major steps over the past years, established a solid international customer base and is widely respected and appreciated for its unique competences in the field of turnkey solutions. By that, we enable our customers, throughout the lifecycle of the product, to significantly save costs and to focus on their core business. Nordian Capital facilitates us to realize our business strategy to grow in the existing and new markets”

Peter Mertens, CEO of IGS GeboJagema